Extracellular vesicles derived from mesenchymal stromal cells mitigate intestinal toxicity in a mouse model of acute radiation syndrome.
Acute radiation syndrome
Gastrointestinal syndrome
Intestinal epithelial barrier
Medical countermeasures
Mesenchymal stromal cell-derived extracellular vesicles
Journal
Stem cell research & therapy
ISSN: 1757-6512
Titre abrégé: Stem Cell Res Ther
Pays: England
ID NLM: 101527581
Informations de publication
Date de publication:
27 08 2020
27 08 2020
Historique:
received:
28
02
2020
accepted:
17
08
2020
revised:
04
08
2020
entrez:
29
8
2020
pubmed:
29
8
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Human exposure to high doses of radiation resulting in acute radiation syndrome and death can rapidly escalate to a mass casualty catastrophe in the event of nuclear accidents or terrorism. The primary reason is that there is presently no effective treatment option, especially for radiation-induced gastrointestinal syndrome. This syndrome results from disruption of mucosal barrier integrity leading to severe dehydration, blood loss, and sepsis. In this study, we tested whether extracellular vesicles derived from mesenchymal stromal cells (MSC) could reduce radiation-related mucosal barrier damage and reduce radiation-induced animal mortality. Human MSC-derived extracellular vesicles were intravenously administered to NUDE mice, 3, 24, and 48 h after lethal whole-body irradiation (10 Gy). Integrity of the small intestine epithelial barrier was assessed by morphologic analysis, immunostaining for tight junction protein (claudin-3), and in vivo permeability to 4 kDa FITC-labeled dextran. Renewal of the small intestinal epithelium was determined by quantifying epithelial cell apoptosis (TUNEL staining) and proliferation (Ki67 immunostaining). Statistical analyses were performed using one-way ANOVA followed by a Tukey test. Statistical analyses of mouse survival were performed using Kaplan-Meier and Cox methods. We demonstrated that MSC-derived extracellular vesicle treatment reduced by 85% the instantaneous mortality risk in mice subjected to 10 Gy whole-body irradiation and so increased their survival time. This effect could be attributed to the efficacy of MSC-derived extracellular vesicles in reducing mucosal barrier disruption. We showed that the MSC-derived extracellular vesicles improved the renewal of the small intestinal epithelium by stimulating proliferation and inhibiting apoptosis of the epithelial crypt cells. The MSC-derived extracellular vesicles also reduced radiation-induced mucosal permeability as evidenced by the preservation of claudin-3 immunostaining at the tight junctions of the epithelium. MSC-derived extracellular vesicles promote epithelial repair and regeneration and preserve structural integrity of the intestinal epithelium in mice exposed to radiation-induced gastrointestinal toxicity. Our results suggest that the administration of MSC-derived extracellular vesicles could be an effective therapy for limiting acute radiation syndrome.
Sections du résumé
BACKGROUND
Human exposure to high doses of radiation resulting in acute radiation syndrome and death can rapidly escalate to a mass casualty catastrophe in the event of nuclear accidents or terrorism. The primary reason is that there is presently no effective treatment option, especially for radiation-induced gastrointestinal syndrome. This syndrome results from disruption of mucosal barrier integrity leading to severe dehydration, blood loss, and sepsis. In this study, we tested whether extracellular vesicles derived from mesenchymal stromal cells (MSC) could reduce radiation-related mucosal barrier damage and reduce radiation-induced animal mortality.
METHODS
Human MSC-derived extracellular vesicles were intravenously administered to NUDE mice, 3, 24, and 48 h after lethal whole-body irradiation (10 Gy). Integrity of the small intestine epithelial barrier was assessed by morphologic analysis, immunostaining for tight junction protein (claudin-3), and in vivo permeability to 4 kDa FITC-labeled dextran. Renewal of the small intestinal epithelium was determined by quantifying epithelial cell apoptosis (TUNEL staining) and proliferation (Ki67 immunostaining). Statistical analyses were performed using one-way ANOVA followed by a Tukey test. Statistical analyses of mouse survival were performed using Kaplan-Meier and Cox methods.
RESULTS
We demonstrated that MSC-derived extracellular vesicle treatment reduced by 85% the instantaneous mortality risk in mice subjected to 10 Gy whole-body irradiation and so increased their survival time. This effect could be attributed to the efficacy of MSC-derived extracellular vesicles in reducing mucosal barrier disruption. We showed that the MSC-derived extracellular vesicles improved the renewal of the small intestinal epithelium by stimulating proliferation and inhibiting apoptosis of the epithelial crypt cells. The MSC-derived extracellular vesicles also reduced radiation-induced mucosal permeability as evidenced by the preservation of claudin-3 immunostaining at the tight junctions of the epithelium.
CONCLUSIONS
MSC-derived extracellular vesicles promote epithelial repair and regeneration and preserve structural integrity of the intestinal epithelium in mice exposed to radiation-induced gastrointestinal toxicity. Our results suggest that the administration of MSC-derived extracellular vesicles could be an effective therapy for limiting acute radiation syndrome.
Identifiants
pubmed: 32854778
doi: 10.1186/s13287-020-01887-1
pii: 10.1186/s13287-020-01887-1
pmc: PMC7457304
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
371Subventions
Organisme : NIDDK NIH HHS
ID : U01 DK085532
Pays : United States
Organisme : NIDDK NIH HHS
ID : U01 DK103155
Pays : United States
Organisme : NIDDK NIH HHS
ID : U24 DK085532
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI091175
Pays : United States
Références
Int J Radiat Biol. 2011 Aug;87(8):851-68
pubmed: 21417595
Leukemia. 2003 Feb;17(2):474-6
pubmed: 12592355
Cell. 1983 Jul;33(3):967-78
pubmed: 6307529
Cardiovasc Diagn Ther. 2017 Jun;7(3):E4-E6
pubmed: 28567365
Leukemia. 2014 Apr;28(4):970-3
pubmed: 24445866
Rep Pract Oncol Radiother. 2011 Jul 06;16(4):123-30
pubmed: 24376969
J Cell Biol. 1983 Aug;97(2):329-39
pubmed: 6309857
J Extracell Vesicles. 2013 Dec 23;2:
pubmed: 24371518
Stem Cell Res Ther. 2014 Jun 10;5(3):76
pubmed: 24915963
Stem Cells Dev. 2014 Jun 1;23(11):1233-44
pubmed: 24367916
J Extracell Vesicles. 2016 Feb 24;5:29828
pubmed: 26928672
J Pediatr Surg. 2016 Jun;51(6):942-7
pubmed: 27015901
Mil Med Res. 2015 Jan 30;2:2
pubmed: 25722881
Stat Med. 1988 Mar;7(3):435-41
pubmed: 3358023
South Med J. 2010 Jun;103(6):541-6
pubmed: 20710137
PLoS One. 2013 Jul 29;8(7):e70170
pubmed: 23922953
Stem Cells. 2009 May;27(5):1205-11
pubmed: 19418462
J Extracell Vesicles. 2019 Apr 29;8(1):1609206
pubmed: 31069028
Mol Cell Proteomics. 2007 Oct;6(10):1680-9
pubmed: 17565974
Science. 2001 Jul 13;293(5528):293-7
pubmed: 11452123
Sci Transl Med. 2011 Nov 23;3(110):110ra118
pubmed: 22116933
Stem Cell Res. 2010 May;4(3):214-22
pubmed: 20138817
Am J Physiol Gastrointest Liver Physiol. 2016 May 1;310(9):G705-15
pubmed: 26822914
Clin Transl Gastroenterol. 2016 Oct 20;7(10):e196
pubmed: 27763627
Gastroenterology. 2010 Dec;139(6):2093-101
pubmed: 20600011
Ann Intern Med. 2004 Jun 15;140(12):1037-51
pubmed: 15197022
Stem Cell Res Ther. 2013 Apr 25;4(2):34
pubmed: 23618405
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
Trends Cell Biol. 2015 Jun;25(6):364-72
pubmed: 25683921
Radiat Res. 2004 Feb;161(2):123-36
pubmed: 14731078
Radiat Res. 1989 Mar;117(3):480-8
pubmed: 2648450
Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):569-73
pubmed: 2528526
Biochem Biophys Res Commun. 2014 Apr 18;446(4):1165-71
pubmed: 24667602
J Transl Med. 2011 Apr 25;9:47
pubmed: 21513579
Am J Physiol Gastrointest Liver Physiol. 2016 Jul 1;311(1):G105-16
pubmed: 27151944
Immunol Res. 2016 Aug;64(4):831-40
pubmed: 27115513
Ann Hematol. 2006 Oct;85(10):671-9
pubmed: 16896913
Mil Med Res. 2016 May 12;3:17
pubmed: 27182446
Stem Cells. 2017 Dec;35(12):2379-2389
pubmed: 29024236
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Cell Death Differ. 2010 Jun;17(6):952-61
pubmed: 20019749
Nephrol Dial Transplant. 2012 Aug;27(8):3037-42
pubmed: 22851627
J Transl Med. 2015 Feb 01;13:49
pubmed: 25638205
J Cell Biochem. 2006 Aug 1;98(5):1076-84
pubmed: 16619257
Oncotarget. 2016 Jul 12;7(28):44462-44477
pubmed: 27286448
Stem Cells. 2015 Jul;33(7):2158-68
pubmed: 24964196